Imipramine Pamoate NDC 68180-316

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-316Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0316Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68180-316-06	68180031606	30 CAPSULE in 1 BOTTLE (68180-316-06)Marketed from Apr 16, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Imipramine Pamoate
Generic name (nonproprietary): imipramine pamoate
Active ingredients: Imipramine pamoate — 125 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090444
Marketing start: Apr 16, 2010
Listing expires: Dec 31, 2027
Identifiers: Product ID 68180-316_ed1f6e8f-a00b-484e-9431-170fb83ca167SPL ID ed1f6e8f-a00b-484e-9431-170fb83ca167SPL set ID d1dde497-1889-4424-af18-da7ca6459cf3RxCUI 835572, 835577, 835589, 835591UNII MC34P30298UPC 0368180314066, 0368180316060, 0368180315063
Pharmacologic class: Tricyclic Antidepressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468180031606 followed by a unit qualifier and the quantity

Package 68180-0316-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 6, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than other depressive states. One to three weeks of treatment may be needed before optimal therapeutic effects are evident.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090444

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090444
Product	Strength	Form · route	Labeler	Product NDC
Imipramine Pamoate	Imipramine pamoate 75 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4730
Imipramine Pamoate	Imipramine pamoate 75 mg/1	CapsuleOral	Lupin Pharmaceuticals, Inc.	68180-314
Imipramine Pamoate	Imipramine pamoate 100 mg/1	CapsuleOral	Lupin Pharmaceuticals, Inc.	68180-315
Imipramine Pamoate	Imipramine pamoate 150 mg/1	CapsuleOral	Lupin Pharmaceuticals, Inc.	68180-317